<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>(1) This study was to evaluate the anti-cholinesterase (ChE), cognition enhancing and neuroprotective effects of FS-0311, a bis-huperzine B derivative </plain></SENT>
<SENT sid="1" pm="."><plain>(2) ChE activity was evaluated using a spectrophotometric method </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0100543'>Cognitive deficits</z:hpo> in mice were induced by <z:chebi fb="2" ids="16794">scopolamine</z:chebi> or transient <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> and reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Water maze was used to detect the cognitive performance </plain></SENT>
<SENT sid="4" pm="."><plain>PC12 cell injury was induced by beta-amyloid 25-35 (Abeta(25-35)), oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (OGD), or <z:chebi fb="0" ids="15738">staurosporine</z:chebi> treatment </plain></SENT>
<SENT sid="5" pm="."><plain>(3) FS-0311 was a potent, highly specific inhibitor of acetylcholinesterase (AChE) </plain></SENT>
<SENT sid="6" pm="."><plain>FS-0311 bound to AChE in a reversible manner, causing linear mixed-type inhibition </plain></SENT>
<SENT sid="7" pm="."><plain>FS-0311 had a high oral bioavailability and a long duration of AChE inhibitory action in vivo </plain></SENT>
<SENT sid="8" pm="."><plain>FS-0311 was found to antagonize <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> induced by <z:chebi fb="2" ids="16794">scopolamine</z:chebi> or transient <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> and reperfusion in a water maze task </plain></SENT>
<SENT sid="9" pm="."><plain>FS-0311 possessed the ability to protect PC12 cells against Abeta(25-35) <z:chebi fb="7" ids="16670">peptide</z:chebi> toxicity, OGD insult and <z:chebi fb="0" ids="15738">staurosporine</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="10" pm="."><plain>The neuroprotective effects of FS-0311 appeared to reflect an attenuation of <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>(4) With the profile of anti-ChE and neuroprotective activities, FS-0311 might be a promising candidate in <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo>, such as <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and Vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>